Search Results - "Schindler, Nicole"
-
1
Fall Outcomes in Older Adults Following Benzodiazepine/Z-Drug Discontinuation: A Retrospective Cohort Study in an Academic Health System
Published in Drugs & aging (01-10-2024)“…Background Benzodiazepines and z-drugs increase the fall risk in older adults. There is a lack of real-world data examining the association between falls and…”
Get full text
Journal Article -
2
Gender differences in motor and non-motor symptoms in individuals with mild-moderate Parkinson's disease
Published in PloS one (11-01-2023)“…Parkinson's disease (PD) affects both men and women with documented gender differences across functional domains, with findings varying among reports…”
Get full text
Journal Article -
3
Nf1 mutation disrupts activity-dependent oligodendroglial plasticity and motor learning in mice
Published in Nature neuroscience (01-08-2024)“…Neurogenetic disorders, such as neurofibromatosis type 1 (NF1), can cause cognitive and motor impairments, traditionally attributed to intrinsic neuronal…”
Get full text
Journal Article -
4
Mixing tree species associated with arbuscular or ectotrophic mycorrhizae reveals dual mycorrhization and interactive effects on the fungal partners
Published in Ecology and evolution (01-05-2021)“…Recent studies found that the majority of shrub and tree species are associated with both arbuscular mycorrhizal (AM) and ectomycorrhizal (EM) fungi. However,…”
Get full text
Journal Article -
5
Temporal variation of mycorrhization rates in a tree diversity experiment
Published in Ecology and evolution (01-04-2023)“…While mycorrhization rates have been studied in different contexts, not much is known about their temporal patterns across seasons. Here, we asked how…”
Get full text
Journal Article -
6
MODL-07. NF1 MUTATION IN OLIGODENDROCYTE PRECURSOR CELLS INDUCES PRENEOPLASTIC LESIONS IN THE BRAIN
Published in Neuro-oncology (Charlottesville, Va.) (10-11-2023)“…Abstract Oligodendrocyte precursor cells (OPCs) are progenitor cells that give rise to oligodendrocytes in the central nervous system throughout the lifespan…”
Get full text
Journal Article -
7
Microporous Polymer Networks Made by Cyclotrimerization of Commercial, Aromatic Diisocyanates
Published in ACS macro letters (17-11-2015)“…The cyclotrimerization of commercial, aromatic diisocyanates allows for the formation of monolithic, microporous polymer networks with S BET surface areas up…”
Get full text
Journal Article -
8
Abstract B005: Intralesional injections with checkpoint inhibitors and cytokines can modify DCIS lesions with infiltrating T cells
Published in Cancer prevention research (Philadelphia, Pa.) (01-12-2022)“…Abstract Background: Ductal carcinoma in situ (DCIS) is a risk factor for the development of invasive ductal carcinoma. Previous work has shown that an…”
Get full text
Journal Article -
9
Abstract B013: Loss of the extracellular domain of human epidermal growth factor receptor 2 (HER2) p95 isoform is common in large DCIS lesions
Published in Cancer prevention research (Philadelphia, Pa.) (01-12-2022)“…Abstract Background/Aim: Testing for human epidermal growth factor receptor 2 (HER2) positivity in women diagnosed with ductal carcinoma in situ (DCIS) is not…”
Get full text
Journal Article -
10
Relationship between parental history of dementia, motor-cognitive and executive function performance in African American women
Published in Journal of the neurological sciences (15-08-2022)“…People with parental history (PH) of Alzheimer's Disease (AD) and Alzheimer's Disease and related dementias (ADRD) are themselves at risk of developing…”
Get full text
Journal Article -
11
Abstract PR001: Spatial proximity between CD8+ T cells and tumor cells correlates with invasive recurrence in DCIS
Published in Cancer prevention research (Philadelphia, Pa.) (01-12-2022)“…Abstract Purpose: The immune microenvironment in ductal carcinoma in situ (DCIS) and its significance are not well established. In this study, we characterized…”
Get full text
Journal Article -
12
Abstract P1-05-01: The tumor immune microenvironment and HER2 landscape of high-risk ductal carcinoma in situ: The DEFENSE study
Published in Cancer research (Chicago, Ill.) (15-02-2022)“…Abstract Introduction: Ductal carcinoma in situ (DCIS) of the breast is a premalignant lesion representing a spectrum of biology from indolent to aggressive. A…”
Get full text
Journal Article -
13
BENZODIAZEPINE/Z-DRUG DEPRESCRIBING DEFINITIONS AND FALLS OUTCOMES IN ELECTRONIC HEALTH RECORDS
Published in Innovation in aging (21-12-2023)“…Abstract Benzodiazepines and Z-drugs contribute to the burden of falls in older adults; however, there is a lack of data examining the association between…”
Get full text
Journal Article -
14
NFS-09.NF1 MUTATION IN OLIGODENDROCYTE PRECURSOR CELLS LEADS TO PRENEOPLASTIC LESION FORMATION IN THE BRAIN
Published in Neuro-oncology (Charlottesville, Va.) (18-06-2024)“…Oligodendrocyte precursor cells (OPCs) are progenitor cells that give rise to central nervous system oligodendrocytes throughout life. Transcriptomic and…”
Get full text
Journal Article -
15
Remote and In-Person Research Education for People With Parkinson's Disease and Their Care Partners
Published in Families systems & health (01-03-2023)“…Objective: TeleDREAMS, a distance learning version of the Developing a Research Participation Enhancement and Advocacy Training Program for Diverse Seniors…”
Get full text
Journal Article -
16
Abstract OT1-20-02: Intralesional injection of anti-PD-1 (pembrolizumab) and OX40L/IL-23/IL-36 mRNAs (mRNA-2752) results in regression of DCIS characterized by lymphocytic infiltrates
Published in Cancer research (Chicago, Ill.) (01-03-2023)“…Abstract Background: High-grade DCIS with immune infiltrates may represent lesions that are able to be kept in check by the immune system, but still are at…”
Get full text
Journal Article -
17
Gender differences in motor and non-motor symptoms in individuals with mild-moderate Parkinson's disease
Published in PloS one (01-01-2023)“…BackgroundParkinson's disease (PD) affects both men and women with documented gender differences across functional domains, with findings varying among…”
Get full text
Journal Article -
18
Abstract P3-09-01: Characterization of residual disease after neoadjuvant selective estrogen receptor degrader (SERD) therapy using tumor organoids in the I-SPY Endocrine Optimization Protocol (EOP)
Published in Cancer research (Chicago, Ill.) (01-03-2023)“…Abstract Background: Treatment of estrogen receptor (ER)-positive breast cancer with selective estrogen receptor degraders (SERDs) frequently results in the…”
Get full text
Journal Article